Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Can Wealth Of Molecular Data Enable Promise Of Chemoprevention?

Oct 01 2011

• By Bridget Silverman

Related Content

NSCLC Market Snapshot: Promising Biomarkers, Testing Challenges

May 30 2011

Deals Of The Week: Karuna/Vanderbilt, Ipsen/Photocure, Lundbeck/Proximagen

Oct 03 2011

FDA Releases Companion Dx Guidance Broad In Scope, Limited In Detail

Jul 18 2011

Myeloma Foundation Uses Patient Connections To Help Speed Drug Trials

Jan 01 2011

How A Biomarker Revived Synta’s Cancer Drug Elesclomol

Mar 01 2011

Exelixis Employs Novel Adaptive Trial Design To Evaluate Cabozantinib In Multiple Cancers

Jun 01 2011

Variety Of Novel Approaches Marks Next-Gen Cancer Therapies At AACR

May 01 2011

Celgene Expands Agios Collaboration In Cancer Metabolism

Oct 07 2011

FDA Biomedical Innovation Initiative Draws On Familiar Themes

Oct 10 2011

Accelerated Approval Remains “Viable Pathway,” FDA’s Woodcock Says

Jun 27 2011

"Risk Reduction" Indications Face A Higher Bar For Approval, May Require Specialized Prescribers

Dec 13 2010

Prostate Cancer Prevention Endpoint May Have Been Key Problem As ODAC Votes Down BPH sNDAs

Dec 13 2010

Biomarkers Consortium Launches Adaptive Trial To Test Targeted Breast Cancer Drugs

Mar 01 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window